NRAS and cancer: These tumours show a low rate of mutations compared to common cancers, which would make the prediction of mutations by AI more challenging [44,45], although somatic mutations of the KIT gene and its downstream mediators encoded by the KRAS and NRAS genes have shown significance in seminoma [45].